CClinicalTrials.gg
CompletedNCT00462839Updated Apr 14, 2014Results posted

Accuracy of Blood Loss Estimation After Vaginal Delivery

An interventional study of blood loss estimation in Postpartum Hemorrhage, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-04-14.

Sponsored by Northwestern University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Post-partum hemorrhage (PPH) is defined as blood loss greater than 500 mL after vaginal delivery. Delayed diagnosis of PPH is a major cause of maternal morbidity and mortality. Obstetricians estimate blood loss at delivery by visual estimation of blood collected in the obstetric drapes. Blood is often mixed with urine and surgical sponges. The urine, blood, and sponges collect in a cone shaped plastic bag that is suspended from the perineum during delivery. Visual estimation of blood loss is insensitive in diagnosing PPH. In one study visual assessment of blood loss underestimated postpartum blood loss by 33% to 50% compared to an objective measurement of blood loss using photospectrometry. Other studies have shown that the magnitude of underestimation increases as the amount of blood loss is increased. A limitation of previous studies is that there is no "gold standard" for blood loss determination in the third stage of labor. Care providers (obstetricians, anesthesiologists, and labor \& delivery nurses) need to be able to accurately estimate blood loss in order to better care for mothers and prevent morbidity and mortality. It is unknown whether provider type or experience (obstetric and anesthesiology resident, fellow, attending physicians, and nurses) influences the accuracy of blood loss estimation, or whether blood loss estimation can be improved by providing graduated markings on the vaginal delivery drape.

Read the detailed description

Packed red blood cells discarded by the blood bank will be mixed with normal saline to simulate whole blood with a hematocrit of 33%. A total of eight isolated study stations will be set up (study participants will only be able to visualize the vaginal delivery drape for one station at a time). The simulated blood will be mixed with urine and sponges and be placed in suspended blood collection drapes which are used during vaginal deliveries at Northwestern Memorial Hospital. Two types of drapes will be used: drapes without calibrated markings and drapes with calibrated markings. Calibrated volume markings will begin at 500 mL at 500 mL intervals to 2500 mL.

Study participants will be randomized to one of two groups. Randomization will occur in blocks depending on provider type. Group 1 will view the unmarked vaginal collection drapes first and Group 2 will view the collection drapes with the calibrated markings first. Both groups will analyze the initial four study stations in random order. At the completion of the four study stations, the group which evaluated the drapes without markings will cross over to view the stations with calibrated markings and the group that views uncalibrated drapes will then view the calibrated drapes.

Each study participant will view a station and write his/her estimation of blood loss on a data card. Study participants will NOT be allowed to change answers once they have been recorded.

Demographic data on study participants will include provider type, level of training/years of practice, and gender.

02

Conditions studied

  • Postpartum Hemorrhage

Keywords

  • Estimated Blood Loss
  • Obstetrics
  • postpartum hemorrhage
03

In context

Postpartum Hemorrhage

445 studies on the registry are indexed under Postpartum Hemorrhage; 75 are open to participants now.

This study's enrollment of 106 is below the median of 148 across 340 interventional studies indexed under Postpartum Hemorrhage.

Browse Postpartum Hemorrhage studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Any anesthesia or obstetric attending or resident may participate provided that they have rotated through obstetrics/obstetric anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Any provider that does not complete all of the stations will be excluded from analysis. Any participant who chooses to withdraw from the study will also be excluded from the analysis.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    Calibrated drapes viewed first

    Caregivers were shown calibrated drape demonstrating level of blood and asked to estimate amount of blood in collection bag. These same individuals were then crossed over and shown non-calibrated drapes and asked to estimate the amount of blood they contained.

    Procedure: blood loss estimation

  • Active comparator
    Non-calibrated drapes viewed first

    Standard vaginal delivery drape (non-calibrated) was shown to caregiver who was asked to estimate amount of blood. These same individuals were then crossed over and shown calibrated delivery drapes and asked to estimate the amount of blood they contained.

    Procedure: blood loss estimation

Interventions

  • Procedureblood loss estimation

    Participants were randomized in blocks, by provider type to view either the four calibrated stations or the four non-calibrated stations. The order of the volumes within each set of stations was randomized. Participants received a data card for each station on which they wrote the volume estimated. After each station, the data card was collected. Alterations to the estimations were not allowed once the answers were recorded. Subjects were then crossed over to the other group and asked to estimate the blood volumes in the non-calibrated drapes if they had first viewed the calibrated drape or the calibrated drape if they had viewed the non-calibrated drape. The order of viewing the four volumes was again randomized. The volumes were the same at the corresponding station for the calibrated and non-calibrated stations so the impact of the calibration markings on accuracy could be determined.

    Also known as: Estimated Blood Loss (EBL)

06

What researchers measure

Primary outcomes

  1. Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters.

    Two types of drapes were used: drapes with and without volume calibrations. Calibrated drapes had volume markings beginning at 500ml with 500ml increments to a total of 2500ml. The participants were asked to estimate the volume contained in the bag and the difference in milliliters between the estimate and actual volume was calculated.

    Time frame: 1 hour

Secondary outcomes

  1. Number and Type of Care Providers Assigned to Study Arms.

    Time frame: 1 hour

  2. Level of Training

    Time frame: 1 hour

  3. Number of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.

    Time frame: 1 hour

07

Results

Posted Dec 9, 2011
Limitations and caveats
A limitation to our study is that we asked participants to estimate blood loss based on inspection of the conical drape only. We did not ask them to estimate blood loss in hidden places. In addition, this was not an actual delivery but a simulation.

Participant flow

The study was conducted on two separate dates at Prentice Women's Hospital. Eight stations were set up in 8-12 hour periods in an empty labor and delivery room. Participants were randomized in blocks by provider type. The order of the volumes was randomized. Subjects were not informed that the volumes in the two groups were the same.

Viewed First
Participant flow — Viewed First
MilestoneCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
Started5353
Completed5353
Not completed00
Viewed Second
Participant flow — Viewed Second
MilestoneCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
Started5353
Completed5353
Not completed00

Outcome measures

PrimaryDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.

Two types of drapes were used: drapes with and without volume calibrations. Calibrated drapes had volume markings beginning at 500ml with 500ml increments to a total of 2500ml. The participants were asked to estimate the volume contained in the bag and the difference in milliliters between the estimate and actual volume was calculated.

Time frame:
1 hour
Reported as:
Mean · milliliters
Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters.
millilitersCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
300 ml-20.8 (-56.8 to 15.1)-41.7 (-77.7 to -5.7)
500 ml-53.5 (-100.6 to -6.4)-96.0 (-143.0 to -48.8)
1000 ml-32.8 (-150.3 to 84.6)-145.3 (-262.8 to -27.8)
2000 ml-178 (-328.0 to -28.4)-829.8 (-980.0 to -680.0)
Statistical analysis
  • Calibrated Vaginal Delivery Drapes Viewed First vs Noncalibrated Drapes Viewed First · ANOVA · p = <0.05 (Post-hoc comparison of 500ml, 1000ml and 2000ml volumes were greater in the non-calibrated drape first group. Post-hoc comparisons made using Bonferroni correct t-test for 8 comparisons.)
SecondaryNumber and Type of Care Providers Assigned to Study Arms.
Time frame:
1 hour
Reported as:
Number · participants
Number and Type of Care Providers Assigned to Study Arms.
participantsCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
Anesthesia2122
Obstetrics2022
Nursing129
Statistical analysis
  • Calibrated Vaginal Delivery Drapes Viewed First vs Noncalibrated Drapes Viewed First · Chi-squared, Corrected · p = 0.76
SecondaryLevel of Training
Time frame:
1 hour
Reported as:
Number · participants
Level of Training
participantsCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
Attending physician1922
Resident physician2222
Nurse129
Statistical analysis
  • Calibrated Vaginal Delivery Drapes Viewed First vs Noncalibrated Drapes Viewed First · Chi-squared, Corrected · p = 0.72
SecondaryNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.
Time frame:
1 hour
Reported as:
Number · participants
Number of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.
participantsCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed First
< 5 years3029
5-10 years1113
> 10 years1211
Statistical analysis
  • Calibrated Vaginal Delivery Drapes Viewed First vs Noncalibrated Drapes Viewed First · Chi-squared, Corrected · p = 0.89

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Calibrated Vaginal Delivery Drapes Viewed First—0/53 (0%)0/53 (0%)
Noncalibrated Drapes Viewed First—0/53 (0%)0/53 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Calibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed FirstTotal
<=18 years000
Between 18 and 65 years5353106
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Calibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed FirstTotal
Female343266
Male192140
Region of Enrollment
Region of Enrollment(participants)Calibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed FirstTotal
United States5353106
08

Study locations

1 site
  • Northwestern University
    Chicago, Illinois 60611, United States
09

References and documents

Publications

  • C. Beckman. Obstetrics and Gynecology. Post Partum Hemorrhage, Chapter 12. 3rd edition. Lippincott Williams & Wilkins 1998; 154-161.
  • Cunningham FG, Leveno KL, Bloom SL, et al. Williams Obstetrics, 22th ed, New York: McGraw-Hill, 2005.
  • Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, Patted SS, Naik VA, Moss N, Derman RJ. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet. 2006 Jun;93(3):220-4. doi: 10.1016/j.ijgo.2006.02.014. Epub 2006 Apr 12. Erratum In: Int J Gynaecol Obstet. 2006 Dec;95(3):312. PubMed 16626718 ↗
  • Prasertcharoensuk W, Swadpanich U, Lumbiganon P. Accuracy of the blood loss estimation in the third stage of labor. Int J Gynaecol Obstet. 2000 Oct;71(1):69-70. doi: 10.1016/s0020-7292(00)00294-0. No abstract available. PubMed 11044547 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00462839
Lead sponsor
Northwestern University
Responsible party
Cynthia Wong (Professor of Anesthesiology, Northwestern University) — Principal investigator
First posted
Apr 19, 2007
Start date
Jul 2006
Primary completion
Apr 2008
Completion
Apr 2008
Results posted
Dec 9, 2011
Last update
Apr 14, 2014

Study contacts

Cynthia A Wong, M.D.
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion